NGL FINECHEM
Back to Cashflow Statement
|
NGL FINECHEM Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-7.43 Cr | ₹7.18 Cr | ₹-1.46 Cr | ₹1.70 Cr | ₹-0.39 Cr |
What is the latest Net Cash Inflow / Outflow ratio of NGL FINECHEM ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-7.43 Cr |
Mar2023 | ₹7.18 Cr |
Mar2022 | ₹-1.46 Cr |
Mar2021 | ₹1.70 Cr |
Mar2020 | ₹-0.39 Cr |
How is Net Cash Inflow / Outflow of NGL FINECHEM Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-7.43 Cr | Negative | |
Mar2023 | ₹7.18 Cr | Positive | |
Mar2022 | ₹-1.46 Cr | Negative | |
Mar2021 | ₹1.70 Cr | Positive | |
Mar2020 | ₹-0.39 Cr | - |
Compare Net Cash Inflow / Outflow of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹1,003.9 Cr | -1% | -10% | -12.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,132.0 Cr | 2.2% | -5.8% | 22.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,254.0 Cr | 4.1% | -7% | 52% | Stock Analytics | |
CIPLA | ₹116,123.0 Cr | 1.3% | -4.8% | 9.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,573.0 Cr | 2.2% | -10.9% | -0.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,966.9 Cr | 7% | -0.2% | 27.5% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -1% |
-10% |
-12.7% |
SENSEX | 2.8% |
-3.1% |
9% |
You may also like the below Video Courses